Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product

Despite sporadic outbreaks of Ebola virus (EBOV) over the last 4 decades and the recent public health emergency in West Africa, there are still no approved vaccines or therapeutics for the treatment of acute EBOV disease (EVD). In response to the 2014 outbreak, an ovine immunoglobulin therapy was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowall, Stuart D., Jacquot, Frédéric, Landon, John, Rayner, Emma, Hall, Graham, Carbonnelle, Caroline, Raoul, Hervé, Pannetier, Delphine, Cameron, Ian, Coxon, Ruth, Al Abdulla, Ibrahim, Hewson, Roger, Carroll, Miles W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481440/
https://www.ncbi.nlm.nih.gov/pubmed/28642489
http://dx.doi.org/10.1038/s41598-017-03910-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481440/
https://www.ncbi.nlm.nih.gov/pubmed/28642489
http://dx.doi.org/10.1038/s41598-017-03910-7

Ejemplares similares